As of 2025-12-21, the Relative Valuation of Intra-Cellular Therapies Inc (ITCI) is (13.58) USD. This relative valuation is based on P/E multiples. With the latest stock price at 131.87 USD, the upside of Intra-Cellular Therapies Inc based on Relative Valuation is -110.3%.
The range of the Relative Valuation is (13.28) - (13.95) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.6x - 19.9x | 19.0x |
| Forward P/E multiples | 18.9x - 20.6x | 19.7x |
| Fair Price | (13.28) - (13.95) | (13.58) |
| Upside | -110.1% - -110.6% | -110.3% |
| Date | P/E |